- Home
- PBFS vs MRVI Comparison
PBFS vs MRVI Comparison
Compare PBFS & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBFS
- MRVI
- Stock Information
- Founded
- PBFS 1889
- MRVI 2014
- Country
- PBFS United States
- MRVI United States
- Employees
- PBFS N/A
- MRVI N/A
- Industry
- PBFS Banks
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- PBFS Finance
- MRVI Health Care
- Exchange
- PBFS Nasdaq
- MRVI Nasdaq
- Market Cap
- PBFS 287.0M
- MRVI 312.4M
- IPO Year
- PBFS N/A
- MRVI 2020
- Fundamental
- Price
- PBFS $12.39
- MRVI $2.67
- Analyst Decision
- PBFS
- MRVI Hold
- Analyst Count
- PBFS 0
- MRVI 10
- Target Price
- PBFS N/A
- MRVI $6.84
- AVG Volume (30 Days)
- PBFS 36.1K
- MRVI 1.9M
- Earning Date
- PBFS 05-09-2025
- MRVI 08-06-2025
- Dividend Yield
- PBFS N/A
- MRVI N/A
- EPS Growth
- PBFS 27.31
- MRVI N/A
- EPS
- PBFS 0.80
- MRVI N/A
- Revenue
- PBFS $88,641,000.00
- MRVI $241,856,000.00
- Revenue This Year
- PBFS N/A
- MRVI N/A
- Revenue Next Year
- PBFS N/A
- MRVI $10.62
- P/E Ratio
- PBFS $15.34
- MRVI N/A
- Revenue Growth
- PBFS 21.19
- MRVI N/A
- 52 Week Low
- PBFS $10.07
- MRVI $1.67
- 52 Week High
- PBFS $12.65
- MRVI $10.03
- Technical
- Relative Strength Index (RSI)
- PBFS 58.85
- MRVI 59.30
- Support Level
- PBFS $11.91
- MRVI $2.52
- Resistance Level
- PBFS $12.64
- MRVI $2.93
- Average True Range (ATR)
- PBFS 0.41
- MRVI 0.18
- MACD
- PBFS 0.01
- MRVI 0.03
- Stochastic Oscillator
- PBFS 77.39
- MRVI 69.41
About PBFS Pioneer Bancorp Inc.
Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.